Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 22,377 | 16,074 | 277,480 | 20,624 | 26,623 |
| Cost of Goods | 5,046 | 4,783 | 5,031 | 2,401 | 5,783 |
| Gross Profit | 17,331 | 11,291 | 272,449 | 18,223 | 20,840 |
| Operating Expenses | 68,468 | 57,333 | 189,317 | 51,214 | 60,329 |
| Operating Income | -51,091 | -45,259 | 83,163 | -32,590 | -38,706 |
| Other Income | 909 | 1,641 | 884 | 1,351 | 1,543 |
| Pre-tax Income | -50,182 | -43,618 | 84,047 | -31,239 | -37,163 |
| Income Tax | -605 | -768 | 1,641 | 259 | 160 |
| Net Income Continuous | -49,577 | -42,850 | 82,406 | -31,498 | -37,323 |
| Net Income | $-49,577 | $-42,850 | $82,406 | $-31,498 | $-37,323 |
| EPS Basic Total Ops | -0.49 | -0.42 | 0.88 | -0.34 | -0.40 |
| EPS Basic Continuous Ops | -0.49 | -0.42 | 0.88 | -0.34 | -0.40 |
| EPS Diluted Total Ops | -0.49 | -0.42 | 0.88 | -0.34 | -0.40 |
| EPS Diluted Continuous Ops | -0.49 | -0.42 | 0.88 | -0.34 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.64 | -0.42 | 0.86 | -0.34 | -0.40 |
| EBITDA(a) | $-48,759 | $-43,048 | $85,075 | $-30,721 | $-37,085 |